So, Ojjaara/Omjjara sales amounted to $150 million in the fourth quarter of 2024, more than tripling year-on-year. While sales of the HIV therapy called Cabenuva also did not disappoint ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback